Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
- PMID: 683276
- DOI: 10.1056/NEJM197808312990904
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
Abstract
We examined the relation of carcinoembryonic antigen levels to time, site and extent of recurrence in 358 patients with colorectal cancer. The recurrence rate was higher in patients with Dukes' B and Dukes' C lesions who had preoperative levels higher than 5 ng per milliliter. There was a linear inverse correlation between preoperative levels and estimated mean time to recurrence in patients with Dukes' B and C lesions, ranging from 30 months for a level of 2 to 9.8 months for a level of 70 ng per milliliter. In patients with Dukes' C lesions the median time to recurrence was 13 months if preoperative levels were higher than 5 ng per milliliter, and 28 months if they were lower. Preoperative carcinoembryonic antigen levels in patients with resectable Dukes' B and C cancer provided an additional criterion for allocating these patients to groups at high or low risk for recurrence.
Similar articles
-
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.Anticancer Res. 2000 Nov-Dec;20(6D):5195-8. Anticancer Res. 2000. PMID: 11326694
-
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.Anticancer Res. 1997 Jul-Aug;17(4B):2935-8. Anticancer Res. 1997. PMID: 9329568
-
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.Cancer. 1986 Aug 1;58(3):603-10. doi: 10.1002/1097-0142(19860801)58:3<603::aid-cncr2820580302>3.0.co;2-k. Cancer. 1986. PMID: 3731019
-
[Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].Lakartidningen. 1997 Apr 30;94(18):1716-8. Lakartidningen. 1997. PMID: 9182180 Review. Swedish. No abstract available.
-
The use of carcinoembryonic antigen in the clinical management of colorectal cancer.Surg Clin North Am. 1979 Oct;59(5):831-9. doi: 10.1016/s0039-6109(16)41930-4. Surg Clin North Am. 1979. PMID: 390742 Review.
Cited by
-
Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.Medicine (Baltimore). 2015 Aug;94(31):e1291. doi: 10.1097/MD.0000000000001291. Medicine (Baltimore). 2015. PMID: 26252304 Free PMC article.
-
Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients.Int J Med Sci. 2013 Jun 15;10(8):1022-7. doi: 10.7150/ijms.6686. Print 2013. Int J Med Sci. 2013. PMID: 23801889 Free PMC article.
-
Serum CEA levels in patients with gastric carcinoma correlate with the tumorigenicity of their xenografts in nude mice.Jpn J Surg. 1991 Jan;21(1):32-7. doi: 10.1007/BF02470863. Jpn J Surg. 1991. PMID: 2041238
-
Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.Cancer Metastasis Rev. 1989 Dec;8(3):263-80. doi: 10.1007/BF00047341. Cancer Metastasis Rev. 1989. PMID: 2697474 Review.
-
Measuring quality of care in the treatment of colorectal cancer: the moffitt quality practice initiative.J Oncol Pract. 2007 Mar;3(2):60-5. doi: 10.1200/JOP.0722002. J Oncol Pract. 2007. PMID: 20859375 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
